Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 3rd:

Sarepta Therapeutics, Inc. (SRPT Quick QuoteSRPT - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.6% over the last 60 days.

Sarepta Therapeutics, Inc. Price and Consensus

Sarepta Therapeutics, Inc. price-consensus-chart | Sarepta Therapeutics, Inc. Quote

Sarepta’s shares gained 11.7% over the last month compared with the S&P 500’s advance of 4.3%. The company possesses a Momentum Score  of A.

Sarepta Therapeutics, Inc. Price

Sarepta Therapeutics, Inc. price | Sarepta Therapeutics, Inc. Quote

Wingstop Inc. (WING Quick QuoteWING - Free Report) : This restaurant franchise has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.1% over the last 60 days.

Wingstop Inc. Price and Consensus

Wingstop Inc. price-consensus-chart | Wingstop Inc. Quote

Wingstop’s shares gained 36.7% over the last three months compared with the S&P 500’s advance of 11.2%. The company possesses a Momentum Score of A.

Wingstop Inc. Price

Wingstop Inc. price | Wingstop Inc. Quote

Regeneron Pharmaceuticals, Inc. (REGN Quick QuoteREGN - Free Report) : This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.

Regeneron Pharmaceuticals, Inc. Price and Consensus

Regeneron Pharmaceuticals, Inc. price-consensus-chart | Regeneron Pharmaceuticals, Inc. Quote

Regeneron’s shares gained 26.1% over the last six months compared with the S&P 500’s advance of 7%. The company possesses a Momentum Score of A.

Regeneron Pharmaceuticals, Inc. Price

Regeneron Pharmaceuticals, Inc. price | Regeneron Pharmaceuticals, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.